Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide vs Mesalazine in Collagenous Colitis
NCT00450086Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Mar 2007
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, Salcrozine in collagenous colitis (CC), sponsored by Dr. Falk Pharma GmbH. Started Mar 2007; status: completed.
02
Drugs
budesonideSalcrozine
03
Conditions
collagenous colitis (CC)
Beyond the preview
Go deeper on NCT00450086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450086.